As per thisstudy, the clinical characteristics of this subgroup of CD5+ DLBCL included femalepreponderance, elderly onset, advanced stage at presentation, and with frequentinvolvement of bone marrow.17 Here, CD5 is linked to diffuse large B-cell lymphoma.